Sierra Metals Inc. (SMTSF)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	180	124	118	29	223	538
Market Cap Growth	-4.77%	4.79%	305.74%	-86.99%	-58.47%	96.79%
Enterprise Value	294	230	230	140	289	614
Last Close Price	0.83	0.57	0.55	0.17	1.36	3.25
PE Ratio	7.47	7.83	-	-	-	22.97
PS Ratio	0.61	0.45	0.51	0.18	0.82	2.18
PB Ratio	1.24	0.92	1.07	0.25	1.09	2.24
P/TBV Ratio	1.65	1.22	1.57	0.36	1.32	2.68
P/FCF Ratio	22.64	22.47	19.05	-	472.34	17.35
P/OCF Ratio	2.37	1.90	2.35	4.00	3.09	8.03
EV/Sales Ratio	0.95	0.84	1.00	0.85	1.06	2.49
EV/EBITDA Ratio	3.45	3.70	4.40	3.32	3.16	6.72
EV/EBIT Ratio	7.37	10.53	20.37	-	15.63	12.42
EV/FCF Ratio	36.92	41.72	37.09	-	610.18	19.81
Debt / Equity Ratio	0.66	0.76	0.77	0.75	0.41	0.42
Debt / EBITDA Ratio	1.17	1.65	1.61	2.05	0.91	1.10
Debt / FCF Ratio	12.03	18.64	13.62	-	176.40	3.24
Asset Turnover	0.85	0.81	0.74	0.47	0.65	0.58
Inventory Turnover	7.33	7.50	5.97	5.29	5.92	5.00
Quick Ratio	0.57	0.53	0.28	0.30	0.87	1.70
Current Ratio	0.78	0.74	0.52	0.50	1.20	2.09
Return on Equity (ROE)	21.63%	14.34%	-5.81%	-37.49%	-9.94%	12.11%
Return on Assets (ROA)	6.84%	4.04%	2.26%	-4.93%	2.76%	7.27%
Return on Capital (ROIC)	11.09%	6.32%	3.55%	-7.11%	3.67%	9.47%
Return on Capital Employed (ROCE)	14.40%	8.50%	6.40%	-	6.00%	13.20%
Earnings Yield	13.39%	12.77%	-16.39%	-300.99%	-12.25%	4.35%
FCF Yield	4.42%	4.45%	5.25%	-106.61%	0.21%	5.76%
Dividend Yield	-	-	-	-	2.21%	-
Buyback Yield / Dilution	-15.99%	-22.96%	-5.80%	-0.30%	0.47%	0.40%
Total Shareholder Return	-	-22.96%	-5.80%	-0.30%	2.68%	0.40%

Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.